Under the Medicare Prescription Drug Program, a coverage gap (also called a donut hole) exists after the beneficiary and drug plan pay a certain amount for covered drugs. The coverage gap refers to
A) the large, up-front deductible that must be satisfied if the patient has a prescription for a covered brand-name drug.
B) the temporary gap in coverage that begins when the beneficiary and drug plan pay a certain amount for covered drugs during the year and ends when the catastrophic limit is reached and coverage resumes.
C) the temporary gap in coverage that begins after beneficiaries reach the lifetime limit on catastrophic drug expenses and ends when a new deductible is met and coverage resumes.
D) the temporary gap in coverage that begins when prescription benefits terminate for beneficiaries who attain age 68 and resumes when beneficiaries attain age 72.
Question 2
Which of the following statements regarding the Emergency Unemployment Compensation (EUC) program is true?
A) EUC benefits are limited to individuals who have exhausted regular state benefits and have annual incomes below the federal poverty level.
B) EUC benefits are funded entirely by the federal government.
C) EUC benefits are limited to employees who have lost their job because of a labor dispute.
D) EUC benefits are available on a case-by-case based and awarded at the discretion of the Secretary of Labor.
Subcutaneous drug administration: (d) the needle is removed and the puncture site is covered with an
First-pass effect: (a) drugs are absorbed; (b) drugs enter hepatic portal circulation and go directl
Drug Classification and Description of Use
Obtained from the deadly nightshade plant Atropa belladona, atropine remains a traditional drug ...
Drug Effects
Drug-drug interactions